The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion- associated CMV infection after marrow transplant [see comments]
Abstract
We performed a prospective, randomized trial in CMV seronegative marrow recipients to determine if filtered blood products were as effective as CMV-seronegative blood products for the prevention of transfusion- transmitted CMV infection after marrow transplant. Before transplant, 502 patients were randomized to receive either filtered or seronegative blood products. Patients were monitored for the development of CMV infection and tissue-documented CMV disease between days 21 and 100 after transplant. Infections occurring after day 21 from transplant were considered related to the transfusion of study blood products and, thus, were considered evaluable infections for the purpose of this trial. In the primary analysis of evaluable infections, there were no significant differences between the probability of CMV infection (1.3% v 2.4%, P = 1.00) or disease (0% v 2.4%, P = 1.00) between the seronegative and filtered arms, respectively, or probability of survival (P = .6). In a secondary analysis of all infections occurring from day 0 to 100 post-transplant, although the infection rates were similar, the probability of CMV disease in the filtered arm was greater (2.4% v 0% in the seronegative arm, P = .03). However, the disease rate was still within the prestudy clinically defined acceptable rate of < or = 5%. We conclude that filtration is an effective alternative to the use of seronegative blood products for prevention of transfusion- associated CMV infection in marrow transplant patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk Factors for Cytomegalovirus Infection after Human Marrow Transplantation
Meyers, J. D., Flournoy, N., & Donnall Thomas, E. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/153.3.478 · Cited by 776
Reed, E. C., Bowden, R. A., Dandliker, P. S., Lilleby, K. E., & Meyers, J. D. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-10-783 · Cited by 548
Self-citationBowden, R. A., Sayers, M., Flournoy, N., Newton, B., Banaji, M., Thomas, E. D., & Meyers, J. D. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604173141602 · Cited by 520
Self-citationEmanuel, D., Cunningham, I., Jules-Elysee, K., Brochstein, J. A., Kernan, N. A., Laver, J., Stover, D., White, D. A., Fels, A., Polsky, B., et al. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-10-777 · Cited by 490
Rice, G. P., Schrier, R. D., & Oldstone, M. B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.19.6134 · Cited by 399
Nash, R., Pepe, M., Storb, R., Longton, G., Pettinger, M., Anasetti, C., Appelbaum, F., Bowden, R., Deeg, H., & Doney, K. (1992) · Blood · doi:10.1182/blood.v80.7.1838.1838 · Cited by 377
Self-citationWEISDORF, D., HAKKE, R., BLAZAR, B., MILLER, W., MCGLAVE, P., RAMSAY, N., KERSEY, J., & FILIPOVICH, A. (1991) · Transplantation · doi:10.1097/00007890-199106000-00010 · Cited by 278
Self-citationHERSMAN, J., MEYERS, J. D., THOMAS, E. D., BUCKNER, C. D., & CLIFT, R. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-2-149 · Cited by 196
Cytomegalovirus Infection of Human Blood Cells
Einhorn, L., & Ost, A. (1984) · Journal of Infectious Diseases · doi:10.1093/infdis/149.2.207 · Cited by 176
CYTOMEGALOVIRUS PNEUMONIA AFTER BONE MARROW TRANSPLANTATION
FACTORS, R., Haake, R. J., Weisdorf, D. J., Ramsay, N. K. C., McGlave, P. B., Kersey, J., Thomas, W. J., MCKENZIE, D., & Miller, W. J. (1993) · Transplantation · doi:10.1097/00007890-199306000-00024 · Cited by 156
Self-citation
Cited by
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology
Kozek-Langenecker, S. A., Afshari, A., Albaladejo, P., Santullano, C. A. A., De Robertis, E., Filipescu, D. C., Fries, D., Görlinger, K., Haas, T., Imberger, G., et al. (2013) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32835f4d5b · Cited by 909
Infections in solid-organ transplant recipients
Patel, R., & Paya, C. V. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.1.86 · Cited by 679
Guidelines for the use of platelet transfusions
Estcourt, L. J., Birchall, J., Allard, S., Bassey, S. J., Hersey, P., Kerr, J. P., Mumford, A. D., Stanworth, S. J., Tinegate, H., & the British Committee for Standards in Haematology (2017) · British Journal of Haematology · doi:10.1111/bjh.14423 · Cited by 648
Dykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Metadata
- Authors
- Bowden, R., Slichter, S., Sayers, M., Weisdorf, D., Cays, M., Schoch, G., Banaji, M., Haake, R., Welk, K., & Fisher, L.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1995-11-01
- Volume
- 86
- Issue
- 9
- Pages
- 3598-3603
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1025463489
- Cited by
- 630
- References
- 11
- FWCI
- 24.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion- associated CMV infection after marrow transplant [see comments]. https://app.cochat.ai/papers/10.1182/blood.v86.9.3598.bloodjournal8693598
- The paper
- Bowden, R., Slichter, S., Sayers, M., Weisdorf, D., Cays, M., Schoch, G., Banaji, M., Haake, R., Welk, K., & Fisher, L. (1995). A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion- associated CMV infection after marrow transplant [see comments]. Blood. https://doi.org/10.1182/blood.v86.9.3598.bloodjournal8693598
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.